Related Experiment Video
Updated: Jun 6, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Shp2 suppresses PyMT-induced transformation in mouse fibroblasts by inhibiting Stat3 activity
Ying Yang1, Beibei Jiang, Yingqing Huo
1Laboratory of Vascular Biology, Institute of Molecular Medicine, Peking University, Beijing 100871, China. yingyang76@gmail.com
Abstract:
We have examined the effect of expression of the protein tyrosine phosphatase Shp2 on transformation by the mouse polyoma virus middle T antigen (PyMT). Gain-of-function mutations in Shp2 indicate that it may serve as an oncogene in several types of human leukemia. Paradoxically, however, some catalytically dominant-negative mutations of Shp2 have also been identified in leukemia and neuroblastomas. In this study, we show that Shp2 suppresses transformation induced by PyMT, the major polyoma viral oncoprotein known to act through binding and activation of pp60(c-src). Over-expression of a catalytically inactive Shp2 mutant in NIH3T3 cells significantly enhanced PyMT-induced transformation. Conversely, re-introduction of Shp2 into Shp2-deficient cells strongly inhibited PyMT-induced transformation and tumorigenesis. Short hairpin RNA (shRNA)-mediated Shp2 knockdown potentiated PyMT-induced transformation. Finally, we present evidence that the transformation-suppressive effects of Shp2 are mediated at least partially through the inhibition of signal transducers and activators of transcription 3.
Insights
Protein tyrosine phosphatase Shp2 suppresses transformation induced by mouse polyoma virus middle T antigen (PyMT). Shp2
Area of Science:
- Molecular Biology
- Oncology
- Virology
Background:
- Protein tyrosine phosphatase Shp2 has paradoxical roles, acting as an oncogene in leukemia but with dominant-negative mutations also found in cancers.
- Mouse polyoma virus middle T antigen (PyMT) is a viral oncoprotein that induces cell transformation, often via pp60(c-src) activation.
Purpose of the Study:
- To investigate the role of Shp2 in PyMT-induced cell transformation.
- To elucidate the mechanism by which Shp2 influences transformation mediated by PyMT.
Main Methods:
- Over-expression of wild-type and catalytically inactive Shp2 mutants in NIH3T3 cells.
- Re-introduction of Shp2 into Shp2-deficient cells.
- Short hairpin RNA (shRNA)-mediated knockdown of Shp2.
- Assessment of PyMT-induced transformation and tumorigenesis.
- Analysis of signal transducers and activators of transcription 3 (STAT3) pathway.
Main Results:
- Over-expression of a catalytically inactive Shp2 mutant enhanced PyMT-induced transformation.
- Restoring Shp2 in deficient cells inhibited PyMT-induced transformation and tumorigenesis.
- Shp2 knockdown potentiated PyMT-induced transformation.
- Shp2's suppressive effects on transformation are partly mediated by inhibiting STAT3.
Conclusions:
- Shp2 acts as a tumor suppressor in the context of PyMT-induced transformation.
- The inhibitory effect of Shp2 on transformation involves the suppression of the STAT3 signaling pathway.
Related Concept Videos
The JAK-STAT Signaling Pathway
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Hedgehog Signaling Pathway

